recent publications
-
academic article
- Teirstein, P. S., Topol, E. J. The role of maintenance of certification programs in governance and professionalism JAMA-Journal of the American Medical Association 2015 313:1809-1810 DOI:10.1001/jama.2015.3576 PMID:25965219 PMCID:PMC4751049
- Price, M. J., Murray, S. S., Angiolillo, D. J., Lillie, E., Smith, E. N., Tisch, R. L., Schork, N. J., Teirstein, P. S., Topol, E. J., Investigators, Gift Influence of genetic polymorphisms on the effect of high-and standard-dose clopidogrel after percutaneous coronary intervention the gift (genotype information and functional testing) study Journal of the American College of Cardiology 2012 59:1928-1937 DOI:10.1016/j.jacc.2011.11.068 PMID:22624833
- Gale, A. J., Elias, D. J., Averell, P. M., Teirstein, P. S., Buck, M., Brown, S. D., Polonskaya, Z., Udit, A. K., Finn, M. G. Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients Thrombosis Research 2011 128:E9-E13 DOI:10.1016/j.thromres.2011.03.021 PMID:21496885 PMCID:PMC3153569
- Price, M. J., Angiolillo, D. J., Teirstein, P. S., Lillie, E., Manoukian, S. V., Berger, P. B., Tanguay, J. F., Cannon, C. P., Topol, E. J. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention a time-dependent analysis of the gauging responsiveness with a verifynow p2y12 assay: Impact on thrombosis and safety (gravitas) trial Circulation 2011 124:1132-1137 DOI:10.1161/circulationaha.111.029165 PMID:21875913
- Price, M. J., Berger, P. B., Teirstein, P. S., Tanguay, J. F., Angiolillo, D. J., Spriggs, D., Puri, S., Robbins, M., Garratt, K. N., Bertrand, O. F., Stillablower, M. E., Aragon, J. R., et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA-Journal of the American Medical Association 2011 305:1087-1095 DOI:10.1001/jama.2011.290 PMID:21406646
- Barker, C. M., Murray, S. S., Teirstein, P. S., Kandzari, D. E., Topol, E. J., Price, M. J. Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to cyp2c19 genotype in patients with high on-treatment reactivity JACC-Cardiovascular Interventions 2010 3:1001-1007 DOI:10.1016/j.jcin.2010.07.012 PMID:20965456
- Price, M. J., Berger, P. B., Angiolillo, D. J., Teirstein, P. S., Tanguay, J. F., Kandzari, D. E., Cannon, C. P., Topol, E. J. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the gravitas trial American Heart Journal 2009 157:818-824 DOI:10.1016/j.ahj.2009.02.012 PMID:19376306
- Kao, J., Lincoff, A. M., Topol, E. J., Madrid, A., Price, M. J., Sawhney, N., Teirstein, P. S. Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions Catheterization and Cardiovascular Interventions 2006 68:352-356 DOI:10.1002/ccd.20735 PMID:16892428
- Grise, M. A., Yeager, M. J., Teirstein, P. S. A case of an entrapped rotational atherectomy burr Catheterization and Cardiovascular Interventions 2002 57:31-33 DOI:10.1002/ccd.10263 PMID:12203923
- Tardiff, B. E., Califf, R. M., Tcheng, J. E., Lincoff, A. M., Sigmon, K. N., Harrington, R. A., Mahaffey, K. W., Ohman, E. M., Teirstein, P. S., Blankenship, J. C., Kitt, M. M., Topol, E. J., et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention Journal of the American College of Cardiology 1999 33:88-96 DOI:10.1016/s0735-1097(98)00551-8 PMID:9935014
- Topol, E. J., Califf, R. M., Lincoff, A. M., Tcheng, J. E., Cabot, C. F., Weisman, H. F., Kereiakes, D., Lausten, D., Runyon, J. P., Howard, W., Kelly, T., Muncy, D., et al. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization New England Journal of Medicine 1997 336:1689-1696 PMID:9182212
- Lincoff, A. M., Tcheng, J. E., Califf, R. M., Bass, T., Popma, J. J., Teirstein, P. S., Kleiman, N. S., Hattel, L. J., Anderson, H. V., Ferguson, J. J., Cabot, C. F., Anderson, K. M., et al. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein iib/iiia receptor antibody fragment abciximab (c7e3 fab) during percutaneous coronary revascularization American Journal of Cardiology 1997 79:286-291 PMID:9036746
- Savage, M. P., Fischman, D. L., Schatz, R. A., Teirstein, P. S., Leon, M. B., Baim, D., Ellis, S. G., Topol, E. J., Hirshfeld, J. W., Cleman, M. W., Buchbinder, M., Bailey, S., et al. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation Journal of the American College of Cardiology 1994 24:1207-1212 PMID:7930240
- Scharf, R. E., Tomer, A., Marzec, U. M., Teirstein, P. S., Ruggeri, Z. M., Harker, L. A. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection Arteriosclerosis and Thrombosis 1992 12:1475-1487 PMID:1450179
- Ellis, S. G., Savage, M., Fischman, D., Baim, D. S., Leon, M., Goldberg, S., Hirshfeld, J. W., Cleman, M. W., Teirstein, P. S., Walker, C., Bailey, S., Buchbinder, M., et al. Restenosis after placement of palmaz-schatz stents in native coronary-arteries - initial results of a multicenter experience Circulation 1992 86:1836-1844 PMID:1451256
- Schatz, R. A., Baim, D. S., Leon, M., Ellis, S. G., Goldberg, S., Hirshfeld, J. W., Cleman, M. W., Cabin, H. S., Walker, C., Stagg, J., Buchbinder, M., Teirstein, P. S., et al. Clinical-experience with the palmaz-schatz coronary stent - initial results of a multicenter study Circulation 1991 83:148-161 PMID:1984878